Cyclosporine-induced Hemolytic Uremic Syndrome Following ABO Incompatible Living Donor Renal Transplantation: Case Report

2017 ◽  
Vol 02 (01) ◽  
Author(s):  
Koichi Kozaki ◽  
Kentaro Tani ◽  
Kenji Yuzawa
Keyword(s):  
Case Report ◽  
Renal Transplantation ◽  
Hemolytic Uremic Syndrome ◽  
Living Donor ◽  
Uremic Syndrome

Cyclosporine A-related hemolytic uremic syndrome after living renal transplantation—case report

2002 ◽  
Vol 34 (2) ◽  
pp. 569-571 ◽  
Author(s):  
W Wołyniec ◽  
A Dębska-Ślizień ◽  
A Chamienia ◽  
M Ignacy Pirski ◽  
W Łysiak-Szydłowska ◽  
...  
Keyword(s):  
Case Report ◽  
Renal Transplantation ◽  
Hemolytic Uremic Syndrome ◽  
Cyclosporine A ◽  
Living Renal Transplantation ◽  
Uremic Syndrome

scholarly journals Effective Treatment of a Post-renal Transplantation Patient with Early Recurrent Focal Segmental Glomerulosclerosis and Concomitant Hemolytic Uremic Syndrome, a Case Report

2021 ◽  
pp. 363-371
Author(s):  
Abdullah Alsawadi ◽  
Majed Aloufi ◽  
Ahmed Fatta ◽  
Sahar Almowaina ◽  
Mugahid Elami ◽  
...  
Keyword(s):  
Case Report ◽  
Renal Transplantation ◽  
Hemolytic Uremic Syndrome ◽  
Effective Treatment ◽  
Early Recurrence ◽  
Glomerular Sclerosis ◽  
Focal Segmental Glomerular Sclerosis ◽  
Uremic Syndrome ◽  
Segmental Glomerular Sclerosis ◽  
Transplantation Patient

While recurrence of primary Focal Segmental Glomerular Sclerosis (FSGS) is common post renal transplantation (30%-80%), a concomitant presentation of hemolytic uremic syndrome (HUS) and recurrent FSGS has never been reported. In addition, treatment of recurrent FSGS and HUS post-renal transplantation is challenging; and usually individualized based on center's experience. Here, we reported a case of a pediatric patient with early recurrence of FSGS and concomitant HUS post-renal transplantation. This patient had a complete hematological and renal response following the administration of Eculizumab and Rituximab, respectively. Withdrawal of Tacrolimus as well as plasmapheresis did not improve kidney function. Therefore, we concluded that both Eculizumab and Rituximab could achieve remission in comparable cases when administered at fixed intervals.

scholarly journals Correction to: Hemolytic uremic syndrome caused by sea anemone sting: a case report

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
A. Young Kim ◽  
Kyu Hyang Cho ◽  
Seok Hui Kang ◽  
Jong Won Park ◽  
Jun Young Do ◽  
...  
Keyword(s):  
Case Report ◽  
Hemolytic Uremic Syndrome ◽  
Sea Anemone ◽  
Uremic Syndrome

Atypical Hemolytic Uremic Syndrome Associated with Complement Factor H Mutation and IgA Nephropathy: A Case Report Successfully Treated with Eculizumab

Nephron ◽  
2017 ◽  
Vol 138 (4) ◽  
pp. 324-327 ◽  
Author(s):  
Hironori Nakamura ◽  
Mariko Anayama ◽  
Mutsuki Makino ◽  
Yasushi Makino ◽  
Katsuhiko Tamura ◽  
...  
Keyword(s):  
Case Report ◽  
Hemolytic Uremic Syndrome ◽  
Iga Nephropathy ◽  
Atypical Hemolytic Uremic Syndrome ◽  
Factor H ◽  
Complement Factor H ◽  
Complement Factor ◽  
Uremic Syndrome ◽  
Factor H Mutation

scholarly journals Gemcitabine and Hemolytic Uremic Syndrome: a Case Report

2017 ◽  
Vol 07 (02) ◽  
Author(s):  
Villalba NL ◽  
Merzouki T ◽  
Gonzalez NS ◽  
Ortiz MBA ◽  
Kechida M ◽  
...  
Keyword(s):  
Case Report ◽  
Hemolytic Uremic Syndrome ◽  
Uremic Syndrome

scholarly journals Atypical Hemolytic Uremic Syndrome During Pregnancy: Short Review and Case Report with a Favorable Outcome

2018 ◽  
Vol 01 (02) ◽  
pp. 21-27
Author(s):  
N.A. Zharkin ◽  
M.E. Statsenko ◽  
M.M. Stazharova ◽  
N.A. Burova ◽  
S.A. Prokhvatilov ◽  
...  
Keyword(s):  
Case Report ◽  
Hemolytic Uremic Syndrome ◽  
Atypical Hemolytic Uremic Syndrome ◽  
Short Review ◽  
Favorable Outcome ◽  
Uremic Syndrome
Sign in / Sign up

Export Citation Format

Share Document